Company Filing History:
Years Active: 2018-2023
Title: Jae Gyun Jeong: Innovator in Gene Therapy
Introduction
Jae Gyun Jeong is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of gene therapy, particularly in the development of innovative treatments for diabetic neuropathy. With a total of 4 patents to his name, Jeong's work is paving the way for advancements in medical science.
Latest Patents
Among his latest patents is the invention of an adeno-associated virus (AAV) vector that carries a hybrid HGF gene sequence. This AAV vector allows for the high-yield delivery of the hybrid HGF gene to subjects. Another notable patent focuses on gene therapy for diabetic neuropathy using different isoforms of HGF. This pharmaceutical composition is groundbreaking as it demonstrates the potential to prevent and treat diabetic neuropathy effectively.
Career Highlights
Jae Gyun Jeong has worked with notable companies such as Helixmith Co., Ltd and Viromed Co., Ltd. His experience in these organizations has contributed to his expertise in gene therapy and innovation in medical treatments.
Collaborations
Throughout his career, Jeong has collaborated with esteemed colleagues, including Jong Mook Kim and Seung Shin Yu. These partnerships have further enhanced his research and development efforts in the field.
Conclusion
Jae Gyun Jeong's contributions to gene therapy and his innovative patents highlight his role as a leading inventor in the medical field. His work continues to inspire advancements in treatments for conditions like diabetic neuropathy.